DUBLIN–(BUSINESS WIRE)–The “NeoDynamics AB – Product Pipeline Analysis, 2019 Update” company profile has been added to ResearchAndMarkets.com’s offering.
Summary
NeoDynamics AB (NeoDynamics) is a medical technology company that develops medical solutions for the early detection and treatment of cancer. The company develops the NeoNavia biopsy system that helps to collect samples from breast lesions or axillary lymph nodes for diagnostic analysis of breast abnormalities. Its NeoNavia biopsy system is designed to manage challenges related to axillary lymph node biopsies such as injuring small or large blood vessels, injuring nerves, injuring the thoracic muscles and pneumothorax. The company offers medical solutions to clinicians and physicians. NeoDynamics is headquartered in Stockholm, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NeoDynamics AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Key Topics Covered:
- NeoDynamics AB Company Overview
- NeoDynamics AB Company Snapshot
- NeoDynamics AB Pipeline Products and Ongoing Clinical Trials Overview
- NeoDynamics AB – Pipeline Analysis Overview
- NeoDynamics AB – Key Facts
- NeoDynamics AB – Major Products and Services
- NeoDynamics AB Pipeline Products by Development Stage
- NeoDynamics AB Ongoing Clinical Trials by Trial Status
- NeoDynamics AB Pipeline Products Overview
- Cytotest
- Cytotest Product Overview
- NeoNavia Biopsy System
- NeoNavia Biopsy System Product Overview
- NeoNavia Biopsy System Clinical Trial
- NeoNavia duo
- NeoNavia duo Product Overview
- Preferential Radiofrequency Ablation (PRFA) Device
- Preferential Radiofrequency Ablation (PRFA) Device Product Overview
- NeoDynamics AB – Key Competitors
- NeoDynamics AB – Key Employees
- NeoDynamics AB – Locations And Subsidiaries
- Head Office
- Recent Developments
- NeoDynamics AB, Recent Developments
- Nov 27, 2019: NeoDynamics signs manufacturing agreement for NeoNavia
- Nov 21, 2019: NeoDynamics third quarter jul-sep 2019
- Oct 29, 2019: NeoDynamics receives regulatory approval for new Breast Cancer biopsy system
- Sep 03, 2019: Redeye initiates coverage of NeoDynamics
- Aug 28, 2019: NeoDynamics half-year report 2019
- May 21, 2019: NeoDynamics – Quarterly report January-March 2019
- Apr 26, 2019: NeoDynamics receives advance notice from U.S. Patent Office for a granted biopsy instrument patent
- Apr 10, 2019: New breast biopsy device is evaluated at Karolinska University Hospital in Stockholm
- Feb 21, 2019: NeoDynamics: Year-end report 2018
- Feb 18, 2019: NeoDynamics: New Swedish technology for breast cancer diagnosis tested by leading experts in Germany
- Appendix
- Methodology
- About the Author
- Contact Us
- Disclaimer
Companies Mentioned
- Therawis Diagnostics GmbH
- Sysmex Europe GmbH
- Oncotherm GmbH
For more information about this company profile visit https://www.researchandmarkets.com/r/dugqqc
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900